Marriott Marquis San Diego Marina
San Diego, CA
South Tower – Level 3
Marina Ballroom D-F
November 30, 2018
Friday symposium preceding the 60th American Society of Hematology Annual Meeting
Using a case-based approach, the overall objective of this program is to provide an update on interpretation and optimal application of standard and evolving test repertoire to diagnosis of red blood cell (RBC) disorders.
Combining the clinical and laboratory experience of our faculty, we will illustrate the practical application of testing algorithms derived from the Mayo Clinic practice and illustrate how unnecessary, redundant, and costly laboratory tests can be eliminated while maintaining the highest quality medical care.
Hematologists, oncologists, hematopathologists, and pathologists who provide care for patients with hematological disorders.
Upon completion of the conference, participants should be able to:
- Describe the algorithmic strategy for the diagnostic workup of erythrocytosis and understand the causes of hereditary erythrocytosis.
- Discuss the general approach to evaluation of hemolytic anemia.
- Determine the approach to evaluating a patient with direct antiglobulin negative hemolytic anemia.
- Discuss the approach to evaluating a patient suspected of hereditary hemolytic anemia.
- Apply an algorithmic approach to thrombotic microangiopathies.
Attendance at this Mayo conference does not indicate nor guarantee competence or proficiency in the performance of any procedures that may be discussed or taught in the courses.
Contact the Education Department at 800-533-1710 or 507-284-3156 or email firstname.lastname@example.org.
AMA Category 1™
In support of improving patient care, the Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
The Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Mayo Medical Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E. ® program. This program has been approved for a maximum of 3.0 P.A.C.E® contact hours.
State of California
Mayo Medical Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for State of California. This program has been approved for 3.0 contact hours.
State of Florida
Mayo Medical Laboratories is approved as a Continuing Education Accrediting Agency for the clinical laboratory sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for hematology credit. This program has been approved for 3.0 contact hours.
As a provider accredited by ACCME, the Mayo Clinic College of Medicine and Science (Mayo Clinic School of Continuous Professional Development) must ensure balance, independence, objectivity, and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
National physician payment transparency program
Mayo Medical Laboratories is not an applicable manufacturer or applicable group purchasing organization (GPO). (GPOs, per the Centers for Medicare & Medicaid Services, and this program do not trigger any reporting requirements pursuant to Open Payments [Sunshine Act] legislation.)